Modified MMAF structure
|
Common Name | Modified MMAF | ||
---|---|---|---|---|
CAS Number | 1352202-47-1 | Molecular Weight | 840.10 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C45H73N7O8 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of Modified MMAFModified MMAF, an ADC cytotoxin, can be used in the synthesis of Antibody-drug Conjugate (ADC). Modified MMAF can be used for the targeted treatment of cancer[1]. |
Name | Modified MMAF |
---|
Description | Modified MMAF, an ADC cytotoxin, can be used in the synthesis of Antibody-drug Conjugate (ADC). Modified MMAF can be used for the targeted treatment of cancer[1]. |
---|---|
Related Catalog | |
In Vitro | MMAF inhibits anaplastic large cell lymphoma Karpas 299, breast carcinoma H3396, renal cell carcinoma 786-O and Caki-1 cells with IC50s of 119, 105, 257 and 200 nM in vitro cytotoxicity assay[2]. |
References |
Molecular Formula | C45H73N7O8 |
---|---|
Molecular Weight | 840.10 |